SEC Form 4 · accession 0001209191-15-071068
Kite Pharma, Inc. · KITE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Franz B Humer
Director
Period of report
Sep 9, 2015
Accepted (ET)
Sep 17, 2015 · 1:48 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001510580
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option Grant (Right to Buy)F1 | $56.12 | Sep 9, 2015 | A | 20,000 | A | — | Sep 8, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The shares subject to the stock option vest in 36 equal monthly installments commencing October 9, 2015.